Discontinued — last reported Q3 '18
Hubbell Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 6.8% to $97.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.2%, from $80.60M to $97.70M. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows an upward trend with a 10.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.90M | $58.80M | $57.30M | $53.70M | $53.70M | $59.90M | $60.00M | $54.50M | $57.30M | $57.20M | $85.70M | $82.20M | $82.20M | $82.20M | $82.40M | $80.60M | $80.60M | $82.10M | $104.80M | $97.70M |
| QoQ Change | — | -0.2% | -2.6% | -6.3% | +0.0% | +11.5% | +0.2% | -9.2% | +5.1% | -0.2% | +49.8% | -4.1% | +0.0% | +0.0% | +0.2% | -2.2% | +0.0% | +1.9% | +27.6% | -6.8% |
| YoY Change | — | — | — | — | -8.8% | +1.9% | +4.7% | +1.5% | +6.7% | -4.5% | +42.8% | +50.8% | +43.5% | +43.7% | -3.9% | -1.9% | -1.9% | -0.1% | +27.2% | +21.2% |